Literature DB >> 20855419

Conduction block in acute motor axonal neuropathy.

Norito Kokubun1, Momoka Nishibayashi, Antonino Uncini, Masaaki Odaka, Koichi Hirata, Nobuhiro Yuki.   

Abstract

Guillain-Barré syndrome is divided into two major subtypes, acute inflammatory demyelinating polyneuropathy and acute motor axonal neuropathy. The characteristic electrophysiological features of acute motor axonal neuropathy are reduced amplitude or absence of distal compound muscle action potentials indicating axonal degeneration. In contrast, autopsy study results show early nodal changes in acute motor axonal neuropathy that may produce motor nerve conduction block. Because the presence of conduction block in acute motor axonal neuropathy has yet to be fully recognized, we reviewed how often conduction block occurred and how frequently it either reversed or was followed by axonal degeneration. Based on Ho's criteria, acute motor axonal neuropathy was electrodiagnosed in 18 patients, and repeated motor nerve conduction studies were carried out on their median and ulnar nerves. Forearm segments of these nerves and the across-elbow segments of the ulnar nerve were examined to evaluate conduction block based on the consensus criteria of the American Association of Electrodiagnostic Medicine. Twelve (67%) of the 18 patients with acute motor axonal neuropathy had definite (n=7) or probable (n=5) conduction blocks. Definite conduction block was detected for one patient (6%) in the forearm segments of both nerves and probable conduction block was detected for five patients (28%). Definite conduction block was present across the elbow segment of the ulnar nerve in seven patients (39%) and probable conduction block in two patients (11%). Conduction block was reversible in seven of 12 patients and was followed by axonal degeneration in six. All conduction blocks had disappeared or begun to resolve within three weeks with no electrophysiological evidence of remyelination. One patient showed both reversible conduction block and conduction block followed by axonal degeneration. Clinical features and anti-ganglioside antibody profiles were similar in the patients with (n=12) and without (n=6) conduction block as well as in those with (n=7) and without (n=5) reversible conduction block, indicating that both conditions form a continuum; a pathophysiological spectrum ranging from reversible conduction failure to axonal degeneration, possibly mediated by antibody attack on gangliosides at the axolemma of the nodes of Ranvier, indicating that reversible conduction block and conduction block followed by axonal degeneration and axonal degeneration without conduction block constitute continuous electrophysiological conditions in acute motor axonal neuropathy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20855419     DOI: 10.1093/brain/awq260

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  35 in total

1.  Guillain-Barré syndrome associated with normal or exaggerated tendon reflexes.

Authors:  Nobuhiro Yuki; Norito Kokubun; Satoshi Kuwabara; Yukari Sekiguchi; Masafumi Ito; Masaaki Odaka; Koichi Hirata; Francesca Notturno; Antonino Uncini
Journal:  J Neurol       Date:  2011-12-06       Impact factor: 4.849

2.  Serial electrophysiological findings in Guillain-Barré syndrome not fulfilling AIDP or AMAN criteria.

Authors:  Takafumi Hosokawa; Hideto Nakajima; Kiichi Unoda; Kazushi Yamane; Yoshimitsu Doi; Shimon Ishida; Fumiharu Kimura; Toshiaki Hanafusa
Journal:  J Neurol       Date:  2016-06-08       Impact factor: 4.849

Review 3.  Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors:  Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal:  Nat Rev Neurol       Date:  2014-07-15       Impact factor: 42.937

4.  Reversible conduction failure in acute motor axonal neuropathy.

Authors:  Sreejith Peediackal; James Jose; V Abdul Gafoor; B Smitha
Journal:  Ann Indian Acad Neurol       Date:  2014-01       Impact factor: 1.383

5.  Two unusual variants of Guillain-Barre syndrome.

Authors:  Rajesh Verma; Tejendra S Chaudhari
Journal:  BMJ Case Rep       Date:  2012-11-15

Review 6.  Immune pathogenesis and treatment of multifocal motor neuropathy.

Authors:  Lotte Vlam; Leonard H van den Berg; Elisabeth A Cats; Sanne Piepers; W-Ludo van der Pol
Journal:  J Clin Immunol       Date:  2012-09-02       Impact factor: 8.317

7.  Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barré syndrome.

Authors:  L Schirmer; V Worthington; U Solloch; V Loleit; V Grummel; N Lakdawala; D Grant; R Wassmuth; A H Schmidt; F Gebhardt; T F M Andlauer; J Sauter; A Berthele; M P Lunn; Bernhard Hemmer
Journal:  J Neurol       Date:  2016-08-02       Impact factor: 4.849

8.  Anti-Ganglioside Antibodies Induce Nodal and Axonal Injury via Fcγ Receptor-Mediated Inflammation.

Authors:  Lan He; Gang Zhang; Weiqiang Liu; Tong Gao; Kazim A Sheikh
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

9.  [Association of motor nerve conduction block with different subtypes of childhood Guillain-Barré syndrome].

Authors:  Rui-Di Sun; Jun Jiang; Zhi-Sheng Liu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2020-09

10.  An electrophysiological classification associated with Guillain-Barré syndrome outcomes.

Authors:  Takafumi Hosokawa; Hideto Nakajima; Kiichi Unoda; Kazushi Yamane; Yoshimitsu Doi; Shimon Ishida; Fumiharu Kimura; Toshiaki Hanafusa
Journal:  J Neurol       Date:  2014-08-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.